Here come the newcomer granules, better late than never

Trends in Endocrinology and Metabolism

Volumn 25, Issue 8, 2014, Pages 381-388

  Gaisano, Herbert Y ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Insulin secretion; Newcomer granules; SNARE proteins

Indexed keywords

COMPLEXIN; CYCLIC AMP; EXOCYST; INSULIN; MEMBRANE PROTEIN; MULTIPROTEIN COMPLEX; MUNC18 PROTEIN; MUNC18B PROTEIN; MUNC18C PROTEIN; NUCLEOTIDE EXCHANGE FACTOR ISOFORM 2; RAB 3 INTERACTING MOLECULE ISOFORM 2; RALA PROTEIN; SEC5 PROTEIN; SNARE PROTEIN; SYN 3 PROTEIN; SYN 4 PROTEIN; SYT PROTEIN; UNCLASSIFIED DRUG; VAMP18 PROTEIN;

ACTIN FILAMENT; CELL ORGANELLE; ENZYME SUBSTRATE; EXCITOSOME; EXOCYTOSIS; HUMAN; INSULIN RELEASE; MEMBRANE FUSION; MOLECULAR DOCKING; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW; SECRETORY GRANULE; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; EXOCYTOSIS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; SNARE PROTEINS;

EID: 84904759768     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2014.03.005     Document Type: Review

References (74)

1. Pfeffer S.R. A prize for membrane magic. Cell 2013, 155:1203-1206.
2. Sudhof T.C., Rothman J.E. Membrane fusion: grappling with SNARE and SM proteins. Science 2009, 323:474-477.
3. Kwan E.P., Gaisano H.Y. Rescuing the subprime meltdown in insulin exocytosis in diabetes. Ann. N. Y. Acad. Sci. 2009, 1152:154-164.
4. Gaisano H.Y. Deploying insulin granule-granule fusion to rescue deficient insulin secretion in diabetes. Diabetologia 2012, 55:877-880.
5. Rorsman P., Renstrom E. Insulin granule dynamics in pancreatic beta cells. Diabetologia 2003, 46:1029-1045.
6. Hosker J.P., et al. Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. Metabolism 1989, 38:767-772.
7. Ohara-Imaizumi M., et al. TIRF imaging of docking and fusion of single insulin granule motion in primary rat pancreatic beta-cells: different behaviour of granule motion between normal and Goto-Kakizaki diabetic rat beta-cells. Biochem. J. 2004, 381:13-18.
8. Gaisano H.Y., et al. Abnormal expression of pancreatic islet exocytotic soluble N-ethylmaleimide-sensitive factor attachment protein receptors in Goto-Kakizaki rats is partially restored by phlorizin treatment and accentuated by high glucose treatment. Endocrinology 2002, 143:4218-4226.
9. Ostenson C.G., et al. Impaired gene and protein expression of exocytotic SNARE complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes 2006, 55:435-440.
10. Shibasaki T., et al. Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:19333-19338.
11. Seino S., et al. Dynamics of insulin secretion and the clinical implications for obesity and diabetes. J. Clin. Invest. 2011, 121:2118-2125.
12. Rhee J.S., et al. Beta phorbol ester- and diacylglycerol-induced augmentation of transmitter release is mediated by Munc13s and not by PKCs. Cell 2002, 108:121-133.
13. Shi L., et al. SNARE proteins: one to fuse and three to keep the nascent fusion pore open. Science 2012, 335:1355-1359.
14. Barg S., et al. Syntaxin clusters assemble reversibly at sites of secretory granules in live cells. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:20804-20809.
15. Knowles M.K., et al. Single secretory granules of live cells recruit Syntaxin-1 and synaptosomal associated protein 25 (SNAP-25) in large copy numbers. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:20810-208105.
16. Takahashi N., et al. SNARE conformational changes that prepare vesicles for exocytosis. Cell Metab. 2010, 12:19-29.
17. Kasai H., et al. Distinct initial SNARE configurations underlying the diversity of exocytosis. Physiol. Rev. 2012, 92:1915-1964.
18. Ohara-Imaizumi M., et al. Correlation of Syntaxin-1 and SNAP-25 clusters with docking and fusion of insulin granules analysed by total internal reflection fluorescence microscopy. Diabetologia 2004, 47:2200-2207.
19. Jewell J.L., et al. Exocytosis mechanisms underlying insulin release and glucose uptake: conserved roles for Munc18c and Syntaxin 4. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 298:R517-R553.
20. Oh E., et al. Munc18-1 regulates first-phase insulin release by promoting granule docking to multiple Syntaxin isoforms. J. Biol. Chem. 2012, 287:25821-25833.
21. Ohara-Imaizumi M., et al. Imaging analysis reveals mechanistic differences between first- and second-phase insulin exocytosis. J. Cell Biol. 2007, 177:695-705.
22. Huang X.H., et al. Truncated SNAP-25 (1-197), like botulinum neurotoxin A inhibits insulin secretion from HIT-T15 insulinoma cells. Mol. Endocrinol. 1998, 12:1060-1070.
23. Wheeler M., et al. Characterisation of SNARE protein expression in β-cell lines and pancreatic islets. Endocrinology 1996, 137:1340-1348.
24. Kwan E.P., et al. Munc13-1 deficiency reduces insulin secretion and causes abnormal glucose tolerance. Diabetes 2006, 55:1421-1429.
25. Kwan E.P., et al. Interaction between Munc13-1 and RIM is critical for glucagon-like peptide-1 mediated rescue of exocytotic defects in Munc13-1 deficient pancreatic beta-cells. Diabetes 2007, 56:2579-2588.
26. Gustavsson N., et al. Impaired insulin secretion and glucose intolerance in synaptotagmin-7 null mutant mice. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3992-3997.
27. Duncan R.R., et al. Functional and spatial segregation of secretory vesicle pools according to vesicle age. Nature 2003, 422:176-180.
28. Ivanova A., et al. Age-dependent labeling and imaging of insulin secretory granules. Diabetes 2013, 62:3687-3696.
29. Lam P.P.L., et al. Munc18b is a major mediator of insulin exocytosis in rat pancreatic β-cells. Diabetes 2013, 62:2416-2428.
30. Oh E., Thurmond D.C. Munc18c depletion selectively impairs the sustained phase of insulin release. Diabetes 2009, 58:1165-1174.
31. Antonin W., et al. The R-SNARE endobrevin/VAMP-8 mediates homotypic fusion of early endosomes and late endosomes. Mol. Biol. Cell 2000, 11:3289-3298.
32. Zhao P., et al. Variations in the requirement for v-SNAREs in GLUT4 trafficking in adipocytes. J. Cell Sci. 2009, 122:3472-3480.
33. Cosen-Binker L.I., et al. VAMP8 is the v-SNARE that mediates basolateral exocytosis in a mouse model of alcoholic pancreatitis. J. Clin. Invest. 2008, 118:2535-2551.
34. Zhu D., et al. Dual role of VAMP8 in regulating insulin exocytosis and islet beta cell growth. Cell Metab. 2012, 16:238-249.
35. Zhu D., et al. Syntaxin-3 regulates newcomer insulin granules and compound fusion. Diabetologia 2013, 56:359-369.
36. Takahashi N., et al. Sequential exocytosis of insulin granules is associated with redistribution of SNAP25. J. Cell Biol. 2004, 165:255-262.
37. Takahashi N., et al. Fusion pore dynamics and insulin granule exocytosis in the pancreatic islet. Science 2002, 297:1349-1352.
38. 2+ sensitivity and kinetics of insulin exocytosis differently. J. Biol. Chem. 2011, 286:28026-28040.
39. Kim K., et al. Munc18b is an essential gene in mice whose expression is limiting for secretion by airway epithelial and mast cells. Biochem. J. 2012, 446:383-894.
40. Dolai S., et al. Effects of ethanol metabolites on exocytosis of pancreatic acinar cells in rats. Gastroenterology 2012, 143:832-843.
41. Kang L., et al. Munc13-1 is required for the sustained release of insulin from pancreatic beta cells. Cell Metab. 2006, 3:463-468.
42. Xie L., et al. Role of mammalian homologue of Caenorhabditis elegans unc-13-1 (Munc13-1) in the recruitment of newcomer insulin granules in both first and second phases of glucose-stimulated insulin secretion in mouse islets. Diabetologia 2012, 55:2693-26702.
43. Campbell J.E., Drucker D.J. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 2013, 17:819-837.
44. Ozaki N., et al. cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat. Cell Biol. 2000, 2:805-811.
45. Yasuda T., et al. Rim2alpha determines docking and priming states in insulin granule exocytosis. Cell Metab. 2010, 12:117-129.
46. Li F., et al. Complexin activates and clamps SNAREpins by a common mechanism involving an intermediate energetic state. Nat. Struct. Mol. Biol. 2011, 18:941-946.
47. Krishnakumar S.S., et al. A conformational switch in complexin is required for synaptotagmin to trigger synaptic fusion. Nat. Struct. Mol. Biol. 2011, 18:934-940.
48. Abderrahmani A., et al. Complexin I regulates glucose-induced secretion in pancreatic beta-cells. J. Cell Sci. 2004, 117:2239-2247.
49. Tadokoro S., et al. Complexin II regulates degranulation in RBL-2H3 cells by interacting with SNARE complex containing Syntaxin-3. Cell. Immunol. 2010, 261:51-56.
50. Song W.J., et al. Snapin mediates incretin action and augments glucose-dependent insulin secretion. Cell Metab. 2011, 13:308-319.
51. Munson M., Novick P. The exocyst defrocked, a framework of rods revealed. Nat. Struct. Mol. Biol. 2006, 13:577-581.
52. Moskalenko S., et al. The exocyst is a Ral effector complex. Nat. Cell Biol. 2002, 4:66-72.
53. Xie L., et al. Exocyst Sec5 regulates exocytosis of newcomer insulin granules underlying biphasic insulin secretion. PLoS ONE 2013, 8:e6756.
54. 2+ channel is functionally coupled to the exocytotic machinery. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:248-253.
55. 2+ channel interacts with synaptic proteins and recruits synaptotagmin to the plasma membrane of Xenopus oocytes. Neuroscience 2004, 128:831-841.
56. 2+ channel null mice. EMBO J. 2003, 22:3844-3854.
57. v2.3 calcium channels control second-phase insulin release. J. Clin. Invest. 2005, 115:146-154.
58. 2δ-1 subunit. Traffic 2013, 14:428-439.
59. Dolphin A.C. Calcium channel diversity: multiple roles of calcium channel subunits. Curr. Opin. Neurobiol. 2009, 19:237-244.
60. Wang Z., Thurmond D.C. Mechanisms of biphasic insulin-granule exocytosis - roles of the cytoskeleton, small GTPases and SNARE proteins. J. Cell Sci. 2009, 122:893-903.
61. Spurlin B.A., Thurmond D.C. Syntaxin 4 facilitates biphasic glucose-stimulated insulin secretion from pancreatic beta-cells. Mol. Endocrinol. 2006, 20:183-189.
62. Oh E., et al. Munc18c heterozygous knockout mice display increased susceptibility for severe glucose intolerance. Diabetes 2005, 54:638-647.
63. Yang C., et al. Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance. J. Clin. Invest. 2001, 107:1311-1318.
64. Pedersen M.G., Sherman A. Newcomer insulin secretory granules as a highly calcium-sensitive pool. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:7432-7436.
65. Kwan E.P., Gaisano H.Y. Glucagon-like peptide 1 regulates sequential and compound exocytosis in pancreatic islet beta-cells. Diabetes 2005, 54:2734-2743.
66. Hoppa M.B., et al. Multivesicular exocytosis in rat pancreatic beta cells. Diabetologia 2012, 55:1001-1012.
67. Fernandez J.M., et al. Capacitance measurements reveal stepwise fusion events in degranulating mast cells. Nature 1984, 312:453-455.
68. Bacaj T., et al. Synaptotagmin-1 and synaptotagmin-7 trigger synchronous and asynchronous phases of neurotransmitter release. Neuron 2013, 80:947-959.
69. Bhatnagar S., et al. Positional cloning of a type 2 diabetes quantitative trait locus; tomosyn-2, a negative regulator of insulin secretion. PLoS Genet. 2011, 7:e1002323.
70. Varlamov O., et al. i-SNAREs: inhibitory SNAREs that fine-tune the specificity of membrane fusion. J. Cell Biol. 2004, 164:79-88.
71. Nemoto T., et al. Sequential-replenishment mechanism of exocytosis in pancreatic acini. Nat. Cell Biol. 2001, 3:253-258.
72. Chan C.B., et al. Beta cell hypertrophy in of fa/fa rats is associated with basal glucose hypersensitivity and reduced SNARE protein expression. Diabetes 1999, 48:997-1005.
73. Kasai K., et al. Docking is not a prerequisite but a temporal constraint for fusion of secretory granules. Traffic 2008, 9:1191-1203.
74. Thorn P., et al. Zymogen granule exocytosis is characterized by long fusion pore openings and preservation of vesicle lipid identity. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:6774-6779.